We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BDX market cap is 23.97M. The company's latest EPS is AUD -0.0254 and P/E is -3.54.
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 0 | 275k | 700k | 4.03M | 5.52M |
Operating Income | 0 | -1.53M | -3.4M | -5.08M | -6.35M |
Net Income | 0 | -1.53M | -3.39M | -5.06M | -6.4M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 15.32M | 4.13M | 10.59M | 8.37M | 12.27M |
Total Liabilities | 85k | 526k | 950k | 3.16M | 3.68M |
Total Equity | 15.23M | 3.61M | 9.64M | 5.21M | 8.59M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | N/A | -1.21M | -3.22M | -6.05M | -4.52M |
Investing | N/A | -4k | -4.03M | 3.64M | -1.15M |
Financing | N/A | 4.2M | 9.41M | 13k | 8.97M |
Market Cap | 23.97M |
Price to Earnings Ratio | -3.54 |
Price to Sales Ratio | 4.11 |
Price to Cash Ratio | 3.5 |
Price to Book Ratio | 2.64 |
Dividend Yield | - |
Shares Outstanding | 252.29M |
Average Volume (1 week) | 27.86k |
Average Volume (1 Month) | 139.17k |
52 Week Change | -3.06% |
52 Week High | 0.185 |
52 Week Low | 0.085 |
Spread (Intraday) | 0 (3.09%) |
Company Name | BCAL Diagnostics Ltd |
Address |
suite 506, level 5 sydney, new south wales 2000 |
Website | https://www.bcaldiagnostics.com |
Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions